9 months The battle over the trillion-dollar weight-loss bonanzaThe Economist

Novo Nordisk and Eli Lilly are making blockbuster drugs. Can they maintain their lead?

Eli Lilly (LLY)

1 day RFK Jr. Spooks Weight-Loss Stocks. Should Eli Lilly, Novo Nordisk Be Worried?Investor's Business Daily X

1 day Goldman Sachs: Eli Lilly and Company (LLY) Is A Top Growth Investor StockInsider Monkey X

2 days Eli Lilly Stock: Unexpected Developments (Rating Downgrade)Seeking Alpha X

2 days Is Now a Good Time to Buy the Dip in Eli Lilly Stock?The Motley Fool X

2 days Is Now a Good Time to Buy the Dip in Eli Lilly Stock?Yahoo Finance X

2 days Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired DropYahoo Finance X

3 days Jim Cramer on Eli Lilly and Company (LLY): ‘I’m Kind Of Blown Away’Insider Monkey X

3 days UnitedHealth, Eli Lilly Lead Market Cap Stock Movers on WednesdayInvesting.com X

3 days Is It Time to Sell Eli Lilly and Pfizer Stocks?The Motley Fool X

3 days Is It Time to Sell Eli Lilly and Pfizer Stocks?Yahoo Finance X

3 days The Zacks Analyst Blog Highlights Eli Lilly, PepsiCo and Morgan StanleyZacks X

4 days Top Research Reports for Eli Lilly, PepsiCo & Morgan StanleyZacks X

4 days LLY Oral Cholesterol Drug Lowers Lipoprotein Levels in Phase II StudyZacks X

4 days Here’s Why Eli Lilly and Company (LLY) is on Detractors’ List of Madison Sustainable Equity FundInsider Monkey X

4 days Makers of Weight-Loss Drugs Want Your Employer to Pay for ThemThe Wall Street Journal X

5 days Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should KnowZacks X

5 days Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-203024/7 Wall St. X

5 days 3 Growth Stocks You Can Buy Right Now Without Any HesitationThe Motley Fool X

6 days Eli Lilly and Novo Want to Shake off Ozempic Copycats. Are They Ready To Meet Demand?The Wall Street Journal X

1 week Three-Stock Lunch: Eli Lilly, Transdigm, & NvidiaYouTube X

1 week Eli Lilly, J&J Sue US Over Rejected Changes To Drug Discounting ProgramYahoo Finance X

1 week Should You Forget Eli Lilly and Buy This Magnificent Biotech Stock Instead?The Motley Fool X

1 week Is Eli Lilly Stock A Sell After Kennedy-Tied Woes Rankled Shares?Investor's Business Daily X

1 week Is AstraZeneca a Buy as It Eyes the Weight Loss Market?The Motley Fool X

1 week 2 Top Growth Stocks to Buy on the DipThe Motley Fool X

1 week Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand?Investor's Business Daily X

1 week Did Viking Therapeutics Just Say “Checkmate” To Eli Lilly?The Motley Fool X

2 weeks Eli Lilly Falls More Than 10% in a Month: Buy, Sell or Hold the Stock?Zacks X

2 weeks Eli Lilly and Company (LLY): Ken Fisher’s Bet on a Pharma Giant’s Growth PotentialInsider Monkey X

2 weeks 1 Stubborn Cloud and 2 Silver Linings for Eli Lilly StockThe Motley Fool X

2 weeks Eli Lilly and Company (LLY): Among the Best Low Volatility Stocks to Invest In NowInsider Monkey X

2 weeks Micron tops list of 20 biggest winners in the S&P 500 this earnings seasonMarketWatch X

2 weeks Eli Lilly Just Hit a Milestone That Disappointed. Here’s Why You Should Still Buy the Stock.The Motley Fool X

2 weeks What Makes Eli Lilly & Co (LLY) a Prospective Investment?Insider Monkey X

2 weeks Eli Lilly Posts a Huge Earnings Miss. Should Investors Be Worried?The Motley Fool X

2 weeks Missed Out on Eli Lilly? Buy This Amazing Growth Stock InsteadThe Motley Fool X

3 weeks Should Investors Buy Weakness in These High-Growth Stocks?Zacks X

3 weeks Is Eli Lilly and Company (LLY) the Best Pharma Stock to Buy Right Now?Insider Monkey X

3 weeks Americans seeking Eli Lilly and Novo Nordisk’s weight-loss drugs turn to compounded marketFast Company X

3 weeks Big Pharma’s Obesity Bonanza Faces New TestsThe Wall Street Journal X

3 weeks Could This Near Trillion-Dollar Stock Be a Millionaire Maker?The Motley Fool X

3 weeks Pharma Stock Roundup: MRK, PFE, ABBV, NVS, LLY’s Q3 Earnings in FocusZacks X

3 weeks Three Buys and a Bail: Microsoft, Eli Lilly, Peloton, and SnapYouTube X

3 weeks Leerink Partnrs Issues Pessimistic Forecast for LLY EarningsMarketBeat X

3 weeks Why Eli Lilly Is a No-Brainer Stock to Buy on the DipThe Motley Fool X

3 weeks Eli Lilly Earnings Have Wall Street Asking New Questions About GLP-1 Drugs. Is Something Going Wrong?Yahoo Finance X

3 weeks Eli Lilly and Company (NYSE:LLY): Among The 10 Best S&P 500 Stocks to Buy According to Hedge FundsInsider Monkey X

3 weeks Are Eli Lilly’s Lowered Expectations a Reason to Sell?The Motley Fool X

3 weeks Eli Lilly’s miss explanation is ‘totally opaque’, says Jim CramerYouTube X

3 weeks Eli Lilly’s drop after earnings is a buying opportunity, says Mizuho’s Jared HolzYouTube X